Frankfurt - Delayed Quote EUR
Telix Pharmaceuticals Limited (T3X.F)
16.89
+1.09
+(6.93%)
At close: 4:56:36 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 9 | 9 |
| Avg. Estimate | -- | -- | 1.28B | 1.65B |
| Low Estimate | -- | -- | 1.21B | 1.42B |
| High Estimate | -- | -- | 1.35B | 1.86B |
| Year Ago Sales | -- | -- | 783.21M | 1.28B |
| Sales Growth (year/est) | -- | -- | 63.00% | 29.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| T3X.F | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
ASPHF Ascentage Pharma Group International
5.83
0.00%
BEAM.MX Beam Therapeutics Inc.
390.00
+4.18%
ADAG Adagene Inc.
1.3900
-2.80%
AAPG Ascentage Pharma Group Internat
25.50
+6.69%
BCTXW BriaCell Therapeutics Corp.
0.1706
+36.48%
SER Serina Therapeutics, Inc.
6.09
+5.36%
RNTX Rein Therapeutics Inc.
1.8300
+0.55%
MBX MBX Biosciences, Inc.
9.27
+3.11%
DSGN Design Therapeutics, Inc.
4.2400
+4.18%
BCAX Bicara Therapeutics Inc.
15.63
+0.77%